A Day Up For Apimeds Pharmaceuticals US, Inc

Mon, Oct 05, 2026 at 07:56 PM

Apimeds Pharmaceuticals US, Inc (APUS:NYSEMKT) soared at $4.59, representing a gain of 42.5%. The stock appeared on our News Catalysts scanner on Mon, Oct 05, 2026 at 09:11 AM in the 'AGREEMENT' category. From Mon, Sep 21, 2026, the stock recorded 50.00% Up Days and 27.27% Green Days

The stock spiked on Fri, Sep 25, 2026 at $9.14 with a volume of 37M+.

About Apimeds Pharmaceuticals US, Inc (APUS:NYSEMKT)

Apimeds Pharmaceuticals US is a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally administered bee venom-based toxin which potentially exhibits...

Top 10 Gainers:

NFT Limited (MI:NYSEMKT), 683%
WISeSat.Space Holdings Corp. (SAIQ:NASDAQ), 260.54%
Schmitt Industries, Inc. (SMIT:NASDAQ), 84.67%
Veea Inc. (VEEA:NASDAQ), 71.77%
PDS Biotechnology Corporation (PDSB:NASDAQ), 60.32%
HeartBeam, Inc. (BEAT:NASDAQ), 50.53%
Apimeds Pharmaceuticals US, Inc (APUS:NYSEMKT), 42.55%
QTREX Quantum Ltd Ord Shs (QTEX:NASDAQ), 40%
Singularity Future Technology Ltd. (SGLY:NASDAQ), 34.1%
PTC Inc. (PTC:NASDAQ), 33.49%